PMID- 8562345 OWN - NLM STAT- MEDLINE DCOM- 19960305 LR - 20190515 IS - 0007-0920 (Print) IS - 1532-1827 (Electronic) IS - 0007-0920 (Linking) VI - 73 IP - 3 DP - 1996 Feb TI - Hepatocyte growth factor/scatter factor is present in most pleural effusion fluids from cancer patients. PG - 377-81 AB - Pleural effusion samples were obtained from 55 patients with malignant disease, including patients with primary lung cancers and those with a variety of other tumours metastatic to the pleura. The effusions were assayed for the presence of hepatocyte growth factor/scatter factor (HGF/SF), by both ELISA and bioassay. The presence of malignant cells in the effusions was also assessed. Detectable amounts of the factor, as judged by both criteria, were found in over 90% of all the effusions, including those from patients with a wide variety of carcinomas and also lymphomas. A wide range of HGF/SF levels were found for all tumour classes, some effusions containing high levels above 4 ng ml-1. It is concluded that tumours within the pleura and adjacent lung tissue are usually exposed to biologically significant levels of HGF/SF. FAU - Eagles, G AU - Eagles G AD - School of Biology, University of East Anglia, Norwich, UK. FAU - Warn, A AU - Warn A FAU - Ball, R Y AU - Ball RY FAU - Baillie-Johnson, H AU - Baillie-Johnson H FAU - Arakaki, N AU - Arakaki N FAU - Daikuhara, Y AU - Daikuhara Y FAU - Warn, R M AU - Warn RM LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - England TA - Br J Cancer JT - British journal of cancer JID - 0370635 RN - 67256-21-7 (Hepatocyte Growth Factor) SB - IM MH - Carcinoma/*metabolism MH - Hepatocyte Growth Factor/*metabolism MH - Humans MH - Leukemia/*metabolism MH - Lymphoma/*metabolism MH - Pleural Effusion/*metabolism MH - Sarcoma/*metabolism PMC - PMC2074438 EDAT- 1996/02/01 00:00 MHDA- 1996/02/01 00:01 CRDT- 1996/02/01 00:00 PHST- 1996/02/01 00:00 [pubmed] PHST- 1996/02/01 00:01 [medline] PHST- 1996/02/01 00:00 [entrez] AID - 10.1038/bjc.1996.64 [doi] PST - ppublish SO - Br J Cancer. 1996 Feb;73(3):377-81. doi: 10.1038/bjc.1996.64.